Epidemiology of multimorbidity in Nepal: A systematic review and meta-analysis.

Autor:	Sinha A; ICMR-Regional Medical Research Centre, Bhubaneswar, India.; South Asian Institute of Health Promotion, Bhubaneswar, India., Suman SS; ICMR-Regional Medical Research Centre, Bhubaneswar, India., Subedi N; Nepal Development Society, Chitwan, Nepal.; Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Melbourne, VIC, Australia., Sahoo KC; ICMR-Regional Medical Research Centre, Bhubaneswar, India., Poudel M; Ministry of Health and Population, Kathmandu, Nepal., Chauhan A; Public Health Foundation of India, Gurugram, India., Sahoo B; ICMR-Regional Medical Research Centre, Bhubaneswar, India., van den Akker M; Institute of General Practice, Goethe University, Frankfurt am Main, Germany., Weller D; Usher Institute, University of Edinburgh, Edinburgh, UK., Mercer SW; Usher Institute, University of Edinburgh, Edinburgh, UK., Pati S; ICMR-Regional Medical Research Centre, Bhubaneswar, India.
Jazyk:	angličtina
Zdroj:	Journal of multimorbidity and comorbidity [J Multimorb Comorb] 2024 Sep 14; Vol. 14, pp. 26335565241284022. Date of Electronic Publication: 2024 Sep 14 (Print Publication: 2024).
DOI:	10.1177/26335565241284022
Abstrakt:	Background: Multimorbidity is rising in low-and middle-income countries such as Nepal, yet the research has not gained pace in this field. We aimed to systematically review the existing multimorbidity literature in Nepal and estimate the prevalence and map its risk factors and consequences. Methods: We reviewed data collated from PubMed, Embase and CINAHL by including original studies that reported prevalence of multimorbidity in Nepal. The quality of included studies was assessed using the Appraisal Tool for Cross-sectional Studies. The summary of the review is presented both qualitatively as well as through meta-analysis to give pooled prevalence. We prospectively registered in PROSPERO (CRD42024499598). Results: We identified 423 studies out of which seven were included in this review. All studies were conducted in a community setting except one which was hospital based. The prevalence reported across various studies ranged from 13.96% to 70.1%. The pooled prevalence of multimorbidity was observed to be 25.05% (95% CI: 16.99 to 34.09). The number of conditions used to assess multimorbidity ranged from four to nine. The major risk factors identified were increasing age, urban residence, and lower literacy rates. Conclusion: A wide variance in the prevalence of multimorbidity was observed. Moreover, multimorbidity assessment tool/conditions considered for assessing multimorbidity were heterogeneous. Competing Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. (© The Author(s) 2024.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu